Impacts of depression and emotional distress on cardiac disease

Wei Jiang1

  • 1Duke University Medical Center, Durham, NC 27710, USA. Jiang001@mc.duke.edu

Insights

Depression significantly increases the risk of ischemic heart disease (IHD). Antidepressant therapy, particularly SSRIs, shows promise for improving depressive symptoms and potentially cardiac outcomes in IHD patients.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Research

Background:

  • Depression is a major risk factor for ischemic heart disease (IHD) and negatively impacts prognosis in patients with IHD and heart failure.
  • Mental stress-induced myocardial ischemia is a key pathway linking depression to increased mortality and morbidity in IHD patients.

Purpose of the Study:

  • To review the current evidence on the effects of treating depression in patients with cardiac disease.
  • To evaluate the safety and efficacy of different antidepressant classes in this population.

Main Methods:

  • Review of clinical trials assessing depression therapy in cardiac patients.
  • Analysis of the safety profiles of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants in patients with cardiac disease.

Main Results:

  • Selective serotonin reuptake inhibitors (SSRIs) are effective and relatively safe for managing depressive symptoms in cardiac patients.
  • Tricyclic antidepressants present a less favorable safety profile for patients with cardiac conditions.
  • Preliminary data suggest SSRI treatment may correlate with improved cardiac outcomes in depressed cardiac patients.

Conclusions:

  • SSRIs are a viable treatment option for depression in patients with IHD, offering symptomatic relief and potential cardiac benefits.
  • Further research is necessary to definitively establish the impact of antidepressant therapy on long-term cardiac outcomes.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...